Huntington S Disease Foundation

Analysis

Huntington S Disease Foundation is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in June 1974, 52 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Huntington S Disease Foundation reported income of $2.6m and spending of $4.7m, spending 184% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $2.0m to $2.6m (+27%), an average of +6.2% a year. The sharpest change came in the year to December 2020, when income rose by 100%. Over the whole period it spent 89% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Huntington S Disease Foundation sits at the 74th percentile: it is larger than about 74% of them. Against every charity in United States with reported income it ranks in the 88th percentile, and in the 85th percentile within NY. Charities of a similar size with the same main cause include Pact Coalition for Safe and Drug-Free Communities ($2.6m), Gunnison Valley Health Foundation ($2.6m) and St John Paul II Life Center ($2.6m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 81% of the total. Compensation of current officers, directors and key employees was $154k (3.2% of expenses). Other salaries and wages came to $279k. It paid $43k in professional fundraising fees. At year end it held assets of $18.2m against liabilities of $3.1m, net assets of $15.1m. It reported 4 employees.